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Abstract
The results of early animal studies of engineered nanomaterials (ENMs) and air pollution 
epidemiology suggest that it is important to assess the health of ENM workers. Initial 
epidemiological studies of workers’ exposure to ENMs (<100 nm) are reviewed and characterized 
for their study designs, findings, and limitations. Of the 15 studies, 11 were cross-sectional, 4 were 
longitudinal (1 was both cross-sectional and longitudinal in design), and 1 was a descriptive pilot 
study. Generally, the studies used biologic markers as the dependent variables. All 11 cross-
sectional studies showed a positive relationship between various biomarkers and ENM exposures. 
Three of the four longitudinal studies showed a negative relationship; the fourth showed positive 
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findings after a 1-year follow-up. Each study considered exposure to ENMs as the independent 
variable. Exposure was assessed by mass concentration in 10 studies and by particle count in six 
studies. Six of them assessed both mass and particle concentrations. Some of the studies had 
limited exposure data because of inadequate exposure assessment. Generally, exposure levels were 
not very high in comparison to those in human inhalation chamber studies, but there were some 
exceptions. Most studies involved a small sample size, from 2 to 258 exposed workers. These 
studies represent the first wave of epidemiological studies of ENM workers. They are limited by 
small numbers of participants, inconsistent (and in some cases inadequate) exposure assessments, 
generally low exposures, and short intervals between exposure and effect. Still, these studies are a 
foundation for future work; they provide insight into where ENM workers are experiencing 
potentially adverse effects that might be related to ENM exposures.
Keywords
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Introduction
Nanomaterials and advanced materials have been used in commerce since the early 2000s. 
Engineered nanomaterials (ENMs) are now being used in many different types of 
commercially available products, including electronics, medical and health care products, 
advanced polymers, food, textiles, athletic gear, and household products (Bekker et al. 2013; 
Borm et al. 2006). The use of nanomaterials in industrial and consumer applications 
continues to grow. As of April 2015, the publicly available online inventory of ENM-based 
consumer products (http://www.nanotechproject.org/cpi/) contained 1,800 + products. It is 
estimated that in 2015, the market for ENM-containing products will reach the $1 trillion 
milestone (Seal and Karn 2014). The use of nanomaterials in the development of novel 
materials for new purposes has led to an increase in the numbers of workers exposed to 
nano-objects, their aggregates and agglomerates (NOAA) (Bekker et al. 2013; Borm et al. 
2006). There is increasing public, governmental, and scientific interest in the potential 
adverse health effects of ENM exposure.
Most available information about the toxicities of ENMs is from in vivo (animal) or in vitro 
studies. The health effects induced by ENMs in animal inhalation studies include pulmonary 
fibrosis, granuloma and inflammation, cardiovascular effects, oxidative stress damage, 
pleural plaque formation, and lung tumors (Oberdörster et al. 2005; Stern and McNeil 2008; 
Hesterberg et al. 2009, 2010). Most of the evidence for the health effects of nanoparticles on 
humans studied in the past was generated from unintentionally produced ultrafine particles. 
Evidence of human health hazards of ultrafine particles (lung inflammation, oxidative 
damage, worsening of heart disease, atherosclerosis, asthma, and possibly lung cancer) have 
come from air pollution epidemiological studies of ultrafine particles generated by traffic 
pollution and combustion processes, such as diesel exhaust and welding fumes (Hesterberg 
et al. 2009, 2010; International Agency for Research on Cancer 2012; Peters et al. 2004). In 
addition, needle-like fibrous carbon nanotubes (CNTs) induce asbestos-like granuloma 
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formation and increase the likelihood of mesothelioma in a tumor-prone mouse strain 
(National Institute for Occupational Safety and Health 2013). Recently, the International 
Agency for Research on Cancer (IARC 2014) categorized one type of multiwalled CNT 
(MWCNT-7) as possibly carcinogenic to humans (Group 2B) and single-walled CNTs 
(SWCNTs) and MWCNTs (excluding MWCNT-7) as not classifiable as to their 
carcinogenicity to humans (Group 3). Although NIOSH concludes that there is insufficient 
evidence to classify fine titanium dioxide (TiO2) as a potential occupational carcinogen, it 
has determined that ultrafine TiO2 should be considered a potential occupational carcinogen 
(NIOSH 2011).
Although toxicities of ENM have been identified in animal and in vitro studies, few 
epidemiologic study reports on human health effects have been published, in part because 
there is no single nanotechnology industry. Rather, nanotechnology generally permeates all 
industrial sectors, but the actual numbers of workers exposed to ENMs in any company can 
be quite small. A vast number of potential ENMs can be created from the combination of 
physical and chemical characteristics (Schulte et al. 2009). In addition, for many ENMs, 
their development and use are still limited (Schubauer-Berigan et al. 2011). As a result, it is 
technically difficult to identify and assess exposure in cohorts of a size appropriate for 
epidemiologic research (Schulte et al. 2009).
Although health hazards caused by ENMs have not been confirmed in humans, evidence 
accumulating from animal studies suggests that exposure to some nanomaterials could be 
harmful. There is a need to assess the risk of potentially adverse health effects among 
workers handling nanomaterials and to recommend biological markers, as well as preclinical 
and clinical outcomes that might be useful for their periodic examination to prevent late/
delayed effects and identify failures of disease prevention (Bergamaschi et al. 2015; Schulte 
et al. 2008). This review aims to assess published and unpublished reports on epidemiologic 
studies of nanomaterial workers and studies in progress to provide perspective on their 
designs, findings, and limitations.
Materials and methods
The scientific literature was searched to identify completed and in-progress epidemiological 
studies of nanomaterial workers, with no limit on publication year. The keywords 
“nanomaterial,” “nanoparticles,” “nanotubes,” “health effects,” “biomarkers,” “fibrosis,” 
and “epidemiology” were used to search for related articles and/or abstracts from PubMed, 
Medline, websites, and the proceedings or abstract books for conferences or symposiums. 
Studies were included in this review only if human exposure or potential exposure to 
nanoparticles or nanoscaled particles was mentioned in the study design description. Those 
without such a focus on nanoparticles or nanoscaled materials were excluded, as were 
human experimental inhalation chamber studies, animal studies, and in vitro studies. Some 
authors were contacted to learn more about their nanoparticles-related studies.
This review is focused on newly engineered nanomaterials, which we defined as 
nanomaterials newly engineered to become nanosized particles for different or advanced 
applications (typically, not materials made in the past). Although some particles of carbon 
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black, which has been produced and used for a long time, are within the nanosize range, 
carbon black was not categorized as recently engineered material for advanced applications. 
In addition, some epidemiological studies of workers exposed to carbon black might not be 
found with the key word “nanoparticles.” Since we had no other criteria for distinguishing 
what to cite, we excluded carbon black from this review.
For the purposes of this review, we categorized the epidemiological studies as descriptive, 
cross-sectional, and cohort. Observational epidemiological study (in contrast to experimental 
study) includes a descriptive component (such as case report or case study) and an analytic 
component (cross-sectional, case–control, cohort, and panel or longitudinal study) (IARC 
1999). Descriptive epidemiological study focuses on the distribution of disease in terms of 
various characteristics of person (race, age, or sex, for example), place (geographic 
location), and time (a specific year or span of time). A cross-sectional study examines the 
relationship between disease (or other health-related state) and other variables of interest as 
they exist in a defined population at a single point in time or over a short period (such as a 
calendar year). In a cross-sectional survey, the risk factors and outcomes are measured 
simultaneously, and therefore, it may be difficult to determine whether the exposure 
preceded or followed the disease. Cross-sectional study is limited by its ability to draw valid 
conclusions as to the association between a risk factor and health outcome. A cohort study 
focuses on following a group of people with defined characteristics to determine the 
incidence of or mortality due to a specific disease, all causes of death, or some other 
outcomes. The cohort is followed over time, and the occurrence of disease in the different 
exposure groups is measured and compared. A panel study or longitudinal study provides 
longitudinal data on a group of people who are interviewed and/or examined at regular 
intervals over a period of years. Because a longitudinal study tracks the same people, the 
differences observed among them are less likely to be the result of differences across 
populations. Therefore, longitudinal studies make observations of change more accurate, 
although these studies take a lot of time and are expensive.
Results
A total of 14 epidemiologic studies of nanomaterial workers and one descriptive pilot case 
study were identified (Tables 1, 2). These included six published peer-reviewed articles 
(Table 1) (Lee et al. 2012, 2015; Liou et al. 2012; Liao et al. 2014a, b; Wu et al. 2014) and 
nine unpublished articles (Table 2), comprising one conference paper (Pelclova et al. 2012), 
one doctoral dissertation (Cui 2013), and seven conference abstracts (Ichihara et al. 2013; 
Fatkhutdinova et al. 2013; Pelclova et al. 2013, 2014a, b; Vermeulen et al. 2014; Liou et al. 
2013). In addition to the study reports published in journals and conference proceedings, we 
found three ongoing epidemiologic studies being conducted in the United States, France, 
and Australia (Schubauer-Berigan et al. 2013; Guseva Canu et al. 2013; Glass et al. 2013), 
but their findings have not been reported.
Nine different populations were evaluated in 15 studies; among them, the two most 
commonly studied were Taiwan populations (Liou et al. 2012; Liao et al. 2014a, b; Wu et al. 
2014; Liou et al. 2013) and Czech Republic populations (Pelclova et al. 2012, 2014a, b). Of 
the 15 studies identified, 11 used a cross-sectional study design (Liou et al. 2012, 2014a, b; 
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Wu et al. 2014; Lee et al. 2015; Cui 2013; Ichihara et al. 2013; Fatkhutdinova et al. 2013; 
Pelclova et al. 2012, 2013, 2014a; Vermeulen et al. 2014), and 4 used a longitudinal study 
design with repeated measurements (panel study) (Liao et al. 2014b; Cui 2013; Liou et al. 
2013; Pelclova et al. 2014b). One was a descriptive pilot study (Lee et al. 2012), and another 
used both cross-sectional and longitudinal study designs (Cui 2013).
The studies involved various types of nanomaterials. CNTs were studied in Korea, Russia, 
and the Netherlands (Lee et al. 2015; Fatkhutdinova et al. 2013; Vermeulen et al. 2014); 
others studied were nanosilver (Korea) (Lee et al. 2012), titanium dioxide (China and Czech 
Republic) (Ichihara et al. 2013; Pelclova et al. 2012, 2013, 2014b), iron oxides (Czech 
Republic) (Pelclova et al. 2014a), and calcium carbonate (China) (Cui 2013).
Biological markers used in these various studies included cardiovascular effect markers, 
lung fibrosis markers, lung inflammation and systemic inflammation markers, nucleic acids, 
lipid and protein oxidative stress markers, antioxidant enzyme activity, and genotoxicity 
markers.
The sample size for each study was small, varying from 2 to 258 ENM-exposed workers. 
Most studies selected nonexposed workers as the comparison group.
Published studies
Six published studies were identified (Table 1). These included a pilot case study (Lee et al. 
2012), four cross-sectional studies (Liou et al. 2012, 2014a; Wu et al. 2014; Lee et al. 2015), 
and one longitudinal study (Liao et al. 2014b). Of the published studies, four involved a 
single group of workers in Taiwan and the other two involved workers in Korea.
All four cross-sectional studies (Liou et al. 2012; Liao et al. 2014a; Wu et al. 2014; Lee et 
al. 2015) and one longitudinal study (Liao et al. 2014b) (Table 1) indicated increased levels 
of various biological markers associated with exposure. The cross-sectional studies found 
reduced levels of antioxidant enzymes (Liou et al. 2012), increased cardiovascular effect 
markers (Liou et al. 2012), reduced memory function (Liou et al. 2012), increased levels of 
fractional exhaled nitric oxide (FENO) (Wu et al. 2014), increased symptoms of sneezing 
and allergic dermatitis (Liou et al. 2012), and increased lipid peroxidation products in 
nanomaterial workers (Lee et al. 2015) (Table 1).
The panel study researchers (Liao et al. 2014b), in comparing examination findings at 6 
months’ follow-up with those at baseline, also found significant decreasing slopes of 
antioxidants SOD and GPX, increasing slope of the cardiovascular effect marker VCAM, 
decreasing slope of the cardiovascular effect marker paraoxonase, and decreasing slopes of 
the small airway damage marker (CC16) and lung function.
Unpublished studies
Table 2 shows nine unpublished epidemiologic studies of nanomaterial workers. In general, 
the information on these studies was obtained from conference abstracts. Because these 
studies presented in conference abstracts or proceedings are otherwise unpublished (with the 
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exception of Cui 2013, a dissertation), it is difficult to provide a complete assessment of 
them. For the most part, seven of these studies were cross-sectional in design (Cui 2013; 
Ichihara et al. 2013; Fatkhutdinova et al. 2013; Pelclova et al. 2012, 2013, 2014a; 
Vermeulen et al. 2014); however, three were longitudinal (repeated panel designs) (Cui 
2013; Liou et al. 2013; Pelclova et al. 2014b). One of them had both cross-sectional and 
panel study elements (Cui 2013) (Table 2).
Three cross-sectional studies occurred in the Czech Republic (Pelclova et al. 2012, 2013, 
2014a), two in China (Cui 2013; Ichihara et al. 2013), and one each in Russia 
(Fatkhutdinova et al. 2013) and the Netherlands (Vermeulen et al. 2014). Longitudinal 
studies were conducted in Taiwan (Liou et al. 2013), China (Cui 2013), and the Czech 
Republic (Pelclova et al. 2014b). The studies were on titanium dioxide (Ichihara et al. 2013; 
Pelclova et al. 2012, 2013, 2014b), CNTs (Fatkhutdinova et al. 2013; Vermeulen et al. 
2014), calcium carbonate (Cui 2013), and iron oxides (Pelclova et al. 2014a).
All seven cross-sectional studies (Table 2) identified increased markers of biological effects. 
The cross-sectional studies found variably increased ratios of low frequency to high 
frequency in heart rate variability (Ichihara et al. 2013), increased IL1β and IL8 levels in 
sputum (Cui 2013), increased TGF-β1 levels in serum and KL-6 levels in induced sputum 
(Fatkhutdinova et al. 2013), increased markers of oxidation of nucleic acids, lipid, and 
proteins (Pelclova et al. 2012, 2013, 2014a, b), and increased concentrations of 
immunological cytokines (Vermeulen et al. 2014).
Only one of the three longitudinal panel studies (Table 2) indicated increased markers of 
biological effects in follow-up study (Pelclova et al. 2014b). All exhaled breath condensate 
(EBC) markers of oxidation of lipids, nucleic acids, and proteins were elevated post-shift in 
2013, in comparison with the unexposed control group (Pelclova et al. 2014b). In addition, 
post-shift elevation of several oxidative stress markers (C9, C12, 8-isoprostane, 8-OHdG, 5-
OHMeU, and 3-NOTyr) was found in 2013 in comparison with post-shift EBC samples in 
2012 (Pelclova et al. 2014b). Post-shift elevation of 8-OHdG, 5-OHMeU, and HNE, in 
comparison with pre-shift EBC samples, was also found in (Pelclova et al. 2012). However, 
no marker was increased in urine, and there was no difference in FENO and EBC pH levels 
(Pelclova et al. 2014b).
Analysis of 11 cross-sectional studies
The 11 cross-sectional studies (Liou et al. 2012; Liao et al. 2014a; Wu et al. 2014; Lee et al. 
2015; Cui 2013; Ichihara et al. 2013; Fatkhutdinova et al. 2013; Pelclova et al. 2012, 2013, 
2014a; Vermeulen et al. 2014) showed biological effects associated with exposure, 
indicative of early adverse health effects with exposure to NOAA; these are summarized in 
Tables 1 and 2. The biological effects were categorized into four organs/systems with their 
affecting markers:
1. Lung: increased lung fibrosis markers (serum TGF-β1 and sputum KL-6) 
(Fatkhutdinova et al. 2013), increased lung inflammation markers (sputum IL-1β 
and IL-8, FENO) (Wu et al. 2014; Cui 2013), and increased EBC LT B4, C4, and 
E4 (Pelclova et al. 2012, 2013, 2014a);
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2. Cardiovascular: increased cardiovascular effect markers (fibrinogen, intercellular 
adhesion molecule [ICAM], and interleukin 6) (Liou et al. 2012), increased LF/HF 
in HRV (Ichihara et al. 2013);
3. Immunological: increased immunological cytokines (Vermeulen et al. 2014);
4. Oxidative damage: increased EBC markers of lipid oxidation, including MDA, 
HNE, HHE, 8-isoprostane, n-hexanal, and C6–C12; markers of oxidation of nucleic 
acids and proteins, including 8-OHdG, 8-OHG, 5-OHMeU, 3-ClTyr, 3-NOTyr, and 
o-Tyr (Pelclova et al. 2012, 2013, 2014a); and urine C6, C7, C10, C12, HHE, 8-
OHG, and 3-ClTyr (Pelclova et al. 2012, 2013, 2014a); and decreased antioxidant 
enzymes [superoxide dismutase (SOD)] and glutathione peroxidase (GPX) (Liou et 
al. 2012).
In addition, one study found excessive sneezing and allergic dermatitis related to work in 
nanomaterial areas (Liao et al. 2014a).
Analysis of four longitudinal studies
Two longitudinal panel studies (Cui 2013; Liou et al. 2013) yielded negative findings (no 
association between nanoparticle exposure and biomarker change), and two panel studies 
(Liao et al. 2014b; Pelclova et al. 2014b) showed positive findings, as summarized in Tables 
1 and 2. The 6-month follow-up study in Taiwan (Liao et al. 2014b) found significant 
decreasing slopes of SOD and GPX, increasing slope of the cardiovascular marker VCAM, 
decreasing slope of paraoxonase, and decreasing slopes of the small airway damage marker 
(CC16) and lung function in follow-up versus baseline examinations. However, the extended 
4-year follow-up study in Taiwan (Liou et al. 2013) showed no significant changes in slopes 
in the five examination periods for any markers, including lung injury markers, 
cardiovascular effect markers, heart rate variability (HRV), inflammation markers, oxidative 
stress and lipid peroxidation markers, comet assay, pulmonary function test, and 
neurobehavioral test.
So far, significantly elevated markers of oxidation of lipids, nucleic acids, and proteins in 
EBC in workers exposed to TiO2 nanoparticles (Pelclova et al. 2014b) are the only known 
biological changes in nanomaterial workers from the 1-year follow-up study by Pelclova et 
al. The post-shift markers in 2013, including 8-isoprostane, 8-OHdG, 8-OHG, 5-OHMeU, 3-
NOTyr, o-Tyr, C7, C9, and C12, were elevated in comparison with post-shift in 2012. There 
was no difference in FENO, pH, and LTs, except for LTC4 (Pelclova et al. 2014b); however, 
that finding may be explained by the exclusion of studied workers with a lower exposure 
risk (level 3), according to Paik (Paik et al. 2008), in the follow-up study. On the other hand, 
the aerosol TiO2 mass concentrations (but not particle number concentrations) were lower in 
the follow-up study (Pelclova et al. 2014b).
Exposure assessment for manufacturing or handling engineered nanoparticles
Although each of the epidemiological studies involved exposure assessment of some type, 
most lacked 8-h time-weighted averages of specific nanomaterials from personal breathing 
zone sampling and lacked fully developed job-exposure matrices. Nonetheless, much of the 
exposure data is useful for making tentative assessments of the exposure-outcome 
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relationship. Exposure and physicochemical characteristics of nanomaterials identified in 
epidemiological studies are summarized in Table 3.
Most of the studied workplaces were manufacturing nanomaterials, and the nanomaterials 
handled were in powder form. The particle diameters reported in this review were less than 
100 nm except for well-characterized CNTs, which have agglomerates up to 100 μm.
Personal and area samples were taken in three CNT studies and analyzed for elemental 
carbon. Researchers monitored respirable fractions in Russia (Fatkhutdinova et al. 2013), 
inhalable fractions in the Netherlands (Vermeulen et al. 2014), and total suspended particles 
in Korea (Lee et al. 2015). The mass concentration of respirable elemental carbon in Russia 
was from 6.2 to 9.3 μg/m3 (in personal sampling) and from 5.5 to 7.3 μg/m3 (in area 
sampling) (Fatkhutdinova et al. 2013). The geometric mean of inhalable CNTs in the 
Netherlands was 42.6 (1.4–1186.5) μg/m3 for the production workers and 4.6 (0.2–59.5) 
μg/m3 for research & development workers (Vermeulen et al. 2014). The mass 
concentrations of total suspended particle elemental carbon in Korea were from 0.54 to 6.11 
μg/m3 (in area sampling) (Lee et al. 2015).
Total mass concentration and particle count number concentrations were measured by 
direct-reading instruments (P-TRAK and DustTRAK DRX) in studies of titanium dioxide 
and iron oxides in the Czech Republic and China. The median total mass concentration of 
TiO2 in the Czech Republic was 1.9 (0.1–27) mg/m3 in 2012 and 0.9 (0.07–16) mg/m3 in 
2013 (Pelclova et al. 2012, 2013, 2014b). The median particle count number concentrations 
were 38 × 103 (3.6 × 103 to 2 × 105) particles/cm3 in 2012 and 14.9 × 103 particles/cm3 in 
2013 (Pelclova et al. 2012, 2013, 2014b). The median total mass concentration of iron 
oxides (Fe2O3 and Fe3O4) in the Czech Republic was 0.13 (0.1–0.32) mg/m3 (Pelclova et al. 
2014a). The median particle count number concentration was 11.8 × 103 (10.2 × 103 to 30.8 
× 103) particles/cm3 (Pelclova et al. 2014a). The percentages of particles with diameter 
smaller than 100 nm were 70 to 90 % in TiO2 exposure and 81 to 98 % in iron oxides 
production, as shown in Table 3 (Pelclova et al. 2012, 2013, 2014a, b). The total mass 
concentration by personal sampling of TiO2 particles was from 10 to 30 mg/m3 in a TiO2-
handling factory in China (Ichihara et al. 2013). Real time, size-dependent nanoscaled 
particle number concentrations were from 1 × 104 to 2 × 105 particles/cm3 (Ichihara et al. 
2013).
In some studies, mass concentrations were monitored for respirable particles in personal 
breathing zone and area samplings, whereas particle number concentration was measured by 
particle counters. Geometric mean mass concentrations of respirable particles were from 
7.24 to 3195.86 μg/m3 for area sampling, and from 44.69 to 10028.40 μg/m3 for personal 
sampling in a calcium carbonate manufacturing factory in China (Cui 2013). Particles in the 
nanometer fraction (0.02–0.3 μm) dominate the number concentration in the size range of 
0.02 to 5 μm. The particle number in nanometer fractions (0.02–0.3 μm) was 0.9 to 7.9 × 
1010/m3 (0.9–7.9 × 104/cm3). Surface area concentration was 1 to 5 × 108 μm2/m3 (1–5 × 
102 μm2/cm3) (Cui 2013).
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For other nanomaterial exposure, only total mass concentration was measured. Total mass 
concentrations of silver in total suspended particles were 0.35 and 1.35 μg/m3 in a Korean 
nanosilver manufacturing company with a completely closed system (Lee et al. 2012).
Discussion
Exposure concentrations in the current epidemiological studies compared with the 
published literature
The selection of methodologies in the exposure assessments involved certain technical 
issues. Usually total mass concentration and particle count number concentrations were 
measured by direct-reading instruments such as P-TRAK and DustTRAK DRX, whereas 
aerosol spectrometers such as SMPS and APS were used for continuous monitoring of 
particle size distribution during an entire 8-h shift, with 5-min sampling intervals (Pelclova 
et al. 2012, 2013, 2014a, b). Random checks were made during the measurements to 
compare total number concentrations determined by SMPS with the P-TRAK values, and 
the differences between averaged values never exceeded 20 %. Similarly, the PM10 mass 
concentrations determined by the DustTRAK DRX were also comparable to the PM10 
values integrated from the APS data (with an assumed particle density of 4 g/cm3 for TiO2) 
(Pelclova et al. 2012, 2013, 2014a, b). In addition, the total number and mass concentrations 
were usually determined as the sum of SMPS and APS integral concentrations without 
taking into account the overlap of the particle size distribution measured by SMPS (14–710 
nm) and APS (0.5–10 μm). Therefore, depending on the particle size distribution, the real 
levels might be lowered by about 10 to 25 % (Pelclova et al. 2012, 2013, 2014a, b). Another 
issue is that direct-reading instruments appear to be less reliable indicators of exposure to 
specific ENM, since they are nonspecific and there are many other industrial sources of 
ultrafine particulates (Dahm et al. 2013). Finally, chemical analysis on workplace aerosols 
was not performed in most studies.
Mass concentrations in the studies in this review were much higher than those reported in 
various published exposures to the same materials (Erdely et al. 2013; Dahm et al. 2012, 
2015; Lee et al. 2011; Huang et al. 2010; Koivisto et al. 2012; Tsai et al. 2011). The 
elemental carbon concentrations reported in this review by Vermeulen et al. (2014) were 
higher than those reported by Dahm et al. (Dahm et al. 2013; Erdely et al. 2013; Dahm et al. 
2012, 2015). The mean concentration of inhalable CNTs reported by Vermeulen et al. 
(2014) in the Netherlands was 42.6 (1.4–1186.5) μg/m3, whereas the average elemental 
carbon concentrations at the inhalable size fraction in eight MWCNT factories in the United 
States ranged from nondetectable to 79.6 μg/m3 with an arithmetic mean of 10.6 μg/m3 and 
a standard deviation of 17.2 or with a geometric mean of 4.21 μg/m3 and a geometric 
standard deviation of 4.15 (Dahm et al. 2013; Erdely et al. 2013; Dahm et al. 2012, 2015).
The titanium dioxide total mass concentrations reported by Ichihara et al. (2013) and 
Pelclova et al. (2012, 2013, 2014b) were also much higher than concentrations reported in 
previous studies (Lee et al. 2011; Huang et al. 2010; Koivisto et al. 2012). The total mass 
concentration of TiO2 particles was from 10 to 30 mg/m3 in China (Ichihara et al. 2013). 
The median total mass concentration of TiO2 in the Czech Republic was 1.9 (0.1–27) mg/m3 
in 2012 and 0.9 (0.07–16) mg/m3 in 2013 (Pelclova et al. 2012, 2013, 2014b). The median 
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concentrations did not exceed the nationally allowed concentrations for inert dust (10 
mg/m3). In a Finnish TiO2 factory, the workers’ average exposure varied from 0.225 to 
0.700 mg/m3, and particle counts from 1.15 × 104 to 20.1 × 104/cm3 were reported; more 
than 90 % of the particles were smaller than 100 nm (Koivisto et al. 2012). Total mass 
concentration of TiO2 ranged from 100 to 4,990 μg/m3 and particle number concentrations 
(particles 15–710 nm in size) ranged from 11,400 to 45,900/cm3 during the reaction in a 
Korean factory that handled nano-TiO2 (Lee et al. 2011). This concentration decreased to 
14,000/cm3 when the reaction was stopped (Lee et al. 2011). The respirable dust 
concentrations obtained by the cyclones in a Taiwan TiO2 pigment factory were 0.487, 
0.688, 0.268, and 0.314 mg/m3 (Huang et al. 2010). The most common particle size in the 
nanoparticle number concentrations of the TiO2 pigments was 30–50 nm, and concentrations 
ranged from 4.9 × 104 to 1.1 × 105 particles/cm3 (Huang et al. 2010).
The mass concentrations of calcium carbonate reported by Cui (2013) were also much 
higher than concentrations reported previously (Tsai et al. 2011). The geometric mass 
concentrations of respirable particles were from 7.24 to 3195.86 μg/m3 for area sampling 
and from 44.69 to 10,028 μg/m3 for personal sampling in China (Cui 2013). The particle 
number in the nanometer fraction (0.02–0.3 μm) was 0.9 to 7.9 × 104/cm3, and the surface 
area concentration was 1 to 5 × 102 μm2/cm3 (Cui 2013). The maximum concentration was 
reported to be 1.85 μg/m3 in a Taiwan calcium carbonate plant (Tsai et al. 2011).
The data on exposure to nanoscaled iron oxides described in this review are apparently the 
first published data on such exposure. The nanosilver concentrations detailed in this review 
(Lee et al. 2012) are similar to the concentrations reported previously by Lee et al. (2011). 
The total mass concentrations of silver nanomaterials were 0.35 and 1.35 μg/m3 in a Korean 
nanosilver manufacturing company with a completely closed system (Lee et al. 2012). The 
silver metal concentrations measured in another factory in Korea ranged from 0.02 to 1.18 
μg/m3 and the number of silver nanoparticles ranged from 57,789 to 2,373,309 particles/cm3 
inside the reactor. The average particle size was 20–30 nm, and the particle count ranged 
from 535 to 25,022 particles/cm3; the wide range in particle sizes was due to agglomeration 
or aggregation after the release of nanoparticles into the workplace air (Lee et al. 2011). In 
contrast, the count of silver nanoparticles manufactured by the wet method ranged from 393 
to 3,526 particles/cm3 with an average size of 50 nm (Lee et al. 2011).
Comparison of cross-sectional and longitudinal panel studies
All 11 cross-sectional studies (Liou et al. 2012; Liao et al. 2014a; Wu et al. 2014; Lee et al. 
2015; Cui 2013; Ichihara et al. 2013; Fatkhutdinova et al. 2013; Pelclova et al. 2012, 2013, 
2014a; Vermeulen et al. 2014) found some biological changes that might be indicative of 
early adverse effects on nanomaterial-handling workers. However, assessing causality with 
lack of temporality is a major limitation to drawing conclusions from cross-sectional studies. 
A positive cross-sectional study might also be related to population-selection bias and 
reporting bias.
In the aforementioned exposure assessment data, both the mass concentrations of 
nanoparticles and the particle counts or surface area concentrations were relatively high 
compared to the data reported previously (Dahm et al. 2013; Erdely et al. 2013; Dahm et al. 
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2012, 2015; Lee et al. 2011; Huang et al. 2010; Koivisto et al. 2012; Tsai et al. 2011). These 
high mass concentrations and high particle counts of nanoscaled particles may contribute to 
the positive findings of all 11 cross-sectional studies. However, most of the exposure 
assessments were less than optimal because they did not show time-weighted assessments 
for each person for each nanomaterial. In addition, direct-reading instruments are 
nonspecific for the engineered nanoparticles of interest and may reflect other industrial 
sources within the workplace (Dahm et al. 2013). Fine and coarse particles have been shown 
to result in cardiopulmonary and genotoxic health effects, in air pollution epidemiological 
studies (McDonnell et al. 2000; Chang et al. 2013). Fine and coarse particles in 
nanotechnology factories might also contribute to positive findings in cross-sectional 
studies. However, no studies controlled for these ambient sources of ultrafine particulates or 
included these sources in their analyses of the effects of specific ENMs.
The longitudinal studies in Taiwan, China, and Czech Republic (Liou et al. 2013; Cui 2013; 
Liao et al. 2014b; Pelclova et al. 2014b) did not show significant biological changes after 
work (post-shift) (Cui 2013) or during longitudinal follow-up (Liou et al. 2013), except for 
the 6-month follow-up study in Taiwan (Liao et al. 2014b) and a 1-year follow-up study of 
workers exposed to TiO2 in Czech Republic (Pelclova et al. 2014b). This discrepancy may 
be attributed to selection bias in the Taiwan cohort studies, where the selection of the study 
population for the cohort was somehow related to the probability of the outcome studied. In 
other words, the selected population might already have related health outcomes associated 
with other hazards or causes, which became confounding factors for investigating 
nanomaterial exposure. The appearance of biological changes in the time period after 
inclusion in the study may be due to the likelihood that the workers with the outcome 
studied were more prone to be recruited as members of the cohort (Törner et al. 2010, 2011). 
Selection bias of this type is likely to be more pronounced shortly after inclusion in the 
cohort. Cross-sectional studies and short-term (such as 6 months) follow-up studies would 
have a high probability of this type of selection bias, resulting in positive findings. After 
some time period, population characteristics leading to inclusion in the cohort could be 
resolved. Removal of observation time and events occurring shortly after inclusion in the 
cohort could reduce the impact of selection bias (Törner et al. 2010, 2011). In order to avoid 
such type of selection bias, the Taiwan panel study was extended to a long-term longitudinal 
study design with five repeated examinations in an interval of 4 years. Consequently, the 
extended 4-year follow-up study in Taiwan (Liou et al. 2013) showed no significant 
difference between exposed workers and controls in the changes of all markers. The 
relatively low fraction of nanoparticles might not have as strong an effect as those induced 
by fine and coarse particles. Therefore, negative findings in longitudinal studies may be due 
to the influence of fine and coarse particles overwhelming the difference between exposed 
and comparison workers for some biological markers.
Based on field studies conducted by the Taiwan Institute of Occupational Safety and Health 
(IOSH) that measured the emission of nanoparticles in different operations or processes in 
nanotechnology industry, as shown in Table 4 (Institute of Occupational Safety and Health 
2012), nanoparticle emissions were found to be quite low in enclosed operations for coating 
nanomaterials, in enclosed operations for mixing or grinding nanopigments, and in wet 
processes for synthesis or centrifuge of nanomaterials. However, nanoparticle emissions 
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could be detected in spray drying of nanomaterials as well as dry processes for polishing, 
milling, and grinding. The Taiwan longitudinal panel study suggested that exposure to 
nanomaterials in study scenarios may not have an impact on cardiopulmonary and oxidative 
damage biomarkers (Liou et al. 2013).
Another possibility is that exposure at the workplaces decreased during longitudinal study 
because high awareness of the potential risk of exposure to nanoparticles led to more 
cautious workplace controls. Reduction of mass aerosol concentration in the second follow-
up study by about 40 % was noted among the Czech TiO2 workers (Pelclova et al. 2014b).
Strengths and weaknesses of current epidemiological studies of nanomaterial workers
The greatest weakness of the epidemiologic research reviewed in this paper is that most of 
the studies were cross-sectional. Thus, inherently they could not demonstrate causality. The 
few longitudinal studies conducted on nanomaterial workers were of a much stronger 
design, although most lacked rigorous exposure assessment.
Most of the studies lacked time-weighted averaged personal breathing zone exposure data. 
In the studies of the Taiwanese cohort where the control banding Nanotool risk-level matrix 
(Paik et al. 2008) was used to categorize the risk level of each participant as a surrogate of 
nanoparticle exposure (Table 3), lack of personal measured-exposure data was particularly 
evident. First, some studies measured total suspended particles (TSPs) or respirable mass 
concentration instead of nanoparticle mass concentration, because of either a shortage of 
equipment or lack of consensus of methodologies for environmental sampling and analysis 
of nanoparticles, especially for CNT fiber counts. Comparing studies is difficult; for 
example, a lack of harmonization was found in elemental carbon measurements for CNT 
exposure. Three CNT studies used different sampling strategies to measure elemental 
carbon. Total suspended particles, inhalable particles, and respirable particles, respectively, 
were used by Lee et al. (2015), Vermeulen et al. (2014), and Fatkhutdinova et al. (2013) in 
CNT studies. This illustrates that harmonization is a necessary element of epidemiological 
research.
Second, scientific evidence is still insufficient for determining which particle size range and 
exposure parameters of nanoparticles should be measured to characterize exposure or which 
instruments or methods are the most appropriate for measuring nanoparticle exposure. Most 
of studies measured nanoparticle mass concentrations instead of nanoparticle counts or 
surface area (Table 3). Although surface area has been found to be highly correlated with 
toxicities of nanoparticles, only one study in this review measured surface area (Cui 2013). 
Four studies (Ichihara et al. 2013; Cui 2013; Pelclova et al. 2012, 2013, 2014a, b) measured 
nanoparticle count in addition to mass concentration. It is also extremely difficult to measure 
the surface area attributable to specific ENMs in air samples. According to the currently 
available technology and instruments, measuring both mass and particle number 
concentrations of exposed particles and identifying particle size distribution are the practical 
approaches at this stage of development to provide appropriate information for exposure 
assessment. The respirable mass appears to be most relevant to present the particles 
containing individual and agglomerate nanoparticles, according to the particle size cut-off 
for the respirable mass. In addition, proper characterizations of the exposed particles 
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(including elemental composition, particle morphology, particle surface chemistry, and other 
particle physical and chemical properties) are important factors that need to be understood to 
analyze the exposure and potential human health effects.
Third, most studies used area sampling instead of personal sampling (which represents 
actual exposure of nanomaterial workers) to measure nanoparticle concentrations, due to a 
lack of consensus on equipment and methodology for personal sampling. A recent study of 
CNT-exposed workers in the U.S. has found that measurements from area samples of the 
same tasks are consistently lower than those from personal breathing zone samples (Dahm et 
al. 2012).
Fourth, it is possible that selection bias occurred in identification of the study population. 
Because some nanotechnology factories and some workers in the selected factory pool 
refused to participate, the study population could not be completely representative. Often, 
highly polluted industries or factories refuse to participate. Therefore, the early health 
effects may have been underestimated on account of the population selection. On the 
contrary, company workers who are concerned more about their health condition may be 
prone to participate in health examinations and report more negative health effects, which 
could lead to a biased evaluation. Another selection bias issue in studies was the selection of 
a nonexposed comparison group. Because of exposure to ultrafine particles in the 
background environment and in the workplace from other sources such as transportation, 
coexposure at work (such as to endotoxin), living close to traffic roads or factories (within 
50 meters), and burning incense or anti-mosquito coils in the house, comparability of the 
workers studied could not be ensured. However, the most appropriate or best comparison 
group is difficult to identify and maintain.
Fifth, quality control and assurance of measurements for detecting biologic markers are 
important, especially for longitudinal repeated measurements. Comparability in precision or 
accuracy in different batches and different years was not reported to be evaluated or ensured. 
Data quality issues such as diurnal variations of some health effect markers were not 
identified. For example, diurnal and seasonal variation in fibrinogen, fibrin D-dimer, C-
reactive protein (CRP), tissue plasminogen activator antigen (t-PA), von Willebrand factor, 
and H2O2 has been reported (Rudnicka et al. 2007; Nowak et al. 2001). Diurnal variation 
should be considered in the collection of biospecimens (blood, urine, and EBC) for studying 
cardiovascular markers and oxidative and lipid peroxidation biomarkers, such that the 
biospecimens are collected in the same time period during follow-up. Alternatively, 
adjustment for collection time should be considered in the data analysis.
Another limitation was the small size of the study populations, which hinders subgroup 
assessments and restricts generalizability of the results. The heterogeneous nanomaterial 
exposures made it difficult to find a sufficiently large group of workers exposed to the same 
nanomaterials and to present biomarker effects of a single nanomaterial. Most of the 
reviewed studies were based on small sample sizes, small factory sizes, and low exposure 
relative to effective doses in human inhalation chamber studies. However, further study is 
needed to investigate whether exposure to higher concentrations of ENMs or working longer 
in exposed jobs (other than operations or processes that were studied in this review) can 
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cause increases in biomarkers of adverse effects. There is a need for more cohort studies in 
countries with well-developed nanotechnology, such as the United States, Germany, United 
Kingdom, France, Belgium, and Switzerland (Bekker et al. 2013; Borm et al. 2006; Seal and 
Karn 2014), in order to reveal the biologic effects in larger samples with higher exposure. 
Epidemiologic studies are ongoing in the United States, France, and Australia (Schubauer-
Berigan et al. 2013; Guseva Canu et al. 2013; Glass et al. 2013); thus, more information on 
biologic effects on nanomaterial workers is expected soon. Descriptions of the exposure 
assessment methods and exposure levels for the U.S. cross-sectional study of CNT-exposed 
workers have been published (Dahm et al. 2015). They include background-corrected 
personal breathing zone measurements of elemental carbon at the respirable and inhalable 
size fraction, as well as transmission electron microscope–based CNT structure counts by 
particle size class.
Another limitation was the use of markers of biologic changes instead of health hazards or 
adverse outcomes. These biomarkers are generally nonspecific with respect to ENM 
exposure and have not all been validated for health effects, and the methods may lack 
sensitivity or specificity. Validated health effect markers should be used to evaluate the 
chronic, long-term health hazards of nanomaterial workers. To date, only one study used 
symptoms and/or diseases as outcomes of health effect. This cross-sectional study found 
sneezing and allergic dermatitis (Liao et al. 2014a) increased in nanomaterial workers. In 
addition, lung function tests (Liou et al. 2012, 2013; Liao et al. 2014b; Cui 2013; Vermeulen 
et al. 2014), FENO (Liou et al. 2012, 2013; Wu et al. 2014; Liao et al. 2014b; Pelclova et al. 
2012; Cui 2013), and heart rate variability (Liou et al. 2012, 2013, 2014b; Ichihara et al. 
2013) were used in several studies.
Finally, in terms of process, the studies raise the issue of what employers and study 
participants are told of the findings. In addition to obtaining Internal Review Board approval 
and informed consent, an important issue is how the findings are interpreted and 
communicated. Generally, participants should be told of their individual and group findings 
(Schulte and Smith 2011). In terms of individual results, participants will want to know if 
the results pertain to their health. Employers need to be informed of group results so that 
they can consider changes in risk management.
Conclusion
According to all available studies, at this stage it is not possible to conclude whether there 
are health effects associated with ENM exposure in workers. That is not surprising, since in 
addition to all the methodological limitations identified above, we are still at an early stage 
of the commercial history of nanotechnology and of the history of studying its health effects. 
Many gaps still need investigation. The most critical part of an ideal epidemiological study 
is to appropriately characterize the exposure and distinguish workers with exposures to each 
specific ENM. There are also questions about what biomarkers will be useful to indicate 
potential hazards. The summary of reviewed studies in this article provides the first step in 
addressing the ultimate question of whether ENM workers are at risk of adverse health 
effects. As such, this review makes a contribution to answering that question. It appears that 
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various categories of biomarkers may be influenced by worker exposures to ENMs, and this 
finding serves to point to where and how future research might be conducted.
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CC16 Clara cell protein
FENO Fractional exhaled nitric oxide
KL-6 Krebs Von den Lungen 6
MIP-1beta Macrophage inflammatory protein-1β
PFT Pulmonary function test
FVC Forced vital capacity
FEV1 Forced expiratory volume at 1 s
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MMF Maximal mid-expiratory flow
PEFR Peak expiratory flow rate
FEF25 % Forced expiratory flow at 25 %
FEF50 % Forced expiratory flow at 50 %
FEF75 % Forced expiratory flow at 75 %
TGF-β1 Transforming growth factor beta-1
Systemic inflammation markers




IL-6sR Interleukin-6 soluble receptor
NF-kβ Nuclear factor-kappaβ
TNFalpha Tumor necrosis factor α
Vascular or endothelial function biomarkers
hsCRP Highly sensitive C-reactive protein
ICAM Intercellular adhesion molecule
IL-6 Interleukin-6
IL-6sR Interleukin-6 soluble receptor
MPO Myeloperoxidase
VCAM Vascular cell adhesion molecule
HRV Heart rate variability
SDNN Standard deviation of all normal to normal R–R intervals
RMSSD The root mean square of successive differences between adjacent normal 
cycles
LF/HF Low frequency/high frequency ratio
LF Low frequency
HF High frequency
VLF Very low frequency
CNT/CNF Carbon nanotube/carbon nanofiber
EBC Exhaled breath condensate
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NAOO Nano-objects their aggregates and agglomerates
UFP Ultrafine particles
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Table 1
Characteristics and findings of six published epidemiological studies on nanomaterial-handling workers
Study type, authors, 
year





 Lee et al. (2012) Korea Nanosilver Blood and urine levels of silver were low in 2 workers. No 




 Liou et al. (2012) Taiwan Variousa Decreased antioxidant enzymes superoxide dismutase (SOD) and 
glutathione peroxidase (GPX) and increased cardiovascular 
markers, fibrinogen, intercellular adhesion molecule (ICAM), and 
interleukin 6 were noted in exposed workers
227/137
 Liao et al. (2014a) Taiwan Variousa The only symptom identified as significantly work-related was 
sneezing. The only disease significantly worsened by work was 
allergic dermatitis
258/200
 Wu et al. (2014) Taiwan Variousa A significant association between risk level 2 of NP exposure and 
FENO. When the multivariate logistic regression model was 
adjusted for confounders, nano-TiO2 in all of the nanomaterial-
exposed categories had a significantly increased risk in FENO > 35 
ppb
241/196
 Lee et al. (2015) Korea MWCNTs The malondialdehyde (MDA), 4-hydroxy-2-hexenal (4-HHE), and 
n-hexanal levels in the EBC of MWCNT manufacturing workers 
were significantly higher than those in the office workers
9/4
Longitudinal
 Liao et al. (2014b) Taiwan Variousa Changes in the antioxidant enzymes (decreased SOD and GPX), 
cardiovascular markers (increased VCAM, decrease of 
paraoxonase), the small airway damage marker (decreased Clara 
cell protein 16), and lung function parameters (decreased MMF, 




Carbon nanotubes, silica dioxide, titanium dioxide, nanosilver, and nanoresin
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Table 2
Nine unpublished epidemiological studies on nanomaterial-handling workers
Study type, authors, 
year (presentation)











Czech Republic TiO2 (70–90 % of 
particles <100 nm)
All pre-shift and post-shift EBC markers were higher in 
the workers, except pre-shift LT D4. Markers of lipid 
oxidation (MDA, HNE, HHE, and 8-isoprostane) were 
elevated (p < 0.001), as were markers of oxidation of 
nucleic acids and proteins: 8-OHdG, 8-OHG, 5-OHMeU, 
3-Cl-Tyr, 3-NOTyr, o-Tyr; LT B4, C4, and E4 (p < 0.001). 
In the workers, EBC pH was lower and FENO was 
elevated in both samples. Pre-shift elevation of the 
markers suggests subacute/chronic effect. Spirometry 
(FEV1 % and FVC %) showed no impairment
20/19
 Ichihara et al. 
(2013) (2013 
NanOEH)
China TiO2 (primary particle 
diameters: 46–560 
nm)
Nanoscaled particle number and age correlated 
significantly with the ratio of low-frequency to high-
frequency heart rate variability, a parameter of 
sympathetic function
4/0
 Cui (2013) (PhD 
thesis, University of 
Washington)
China Calcium carbonate The concentrations of IL 1β (p = 0.043) and IL8 (p = 
0.008) in sputum were statistically greater in the high 
mass-exposure group than in the low mass-exposure 
group. The elevation of ILlβ and IL8 followed a dose–
response pattern with increasing exposure
66–102/0
 Fatkhutdinova et 
al. (2013) (2nd 
International School-
Conference)
Russia Multiwalled carbon 
nanotubes (MWCNT)
It was found that exposure to MWCNT aerosol at 
workplaces may alter the fibrosis biomarkers in blood 
serum and induced sputum. The levels of TGF-βl in serum 
were significantly dependent on exposure to MWCNTs (β 
= 10.47; 95 % BCa = 1.18–51.75); the KL-6 levels in 
induced sputum were significantly higher in the exposure 
group (β = 235.9; 95 % BCa = 21.2–482). Osteopontin 
proved to be an uninformative indicator
11/14
 Pelclova et al. 




Czech Republic TiO2 (70–90 % of 
particles <100 nm)
In the EBC, all C6–C13 n-alkanes were elevated in both 
pre-shift and post-shift samples from workers (p < 0.001) 
and correlated with most markers of oxidation of lipids, 
proteins, and nucleic acids and with Ti levels in the EBC. 
In the urine, C6, C7, C10, C12, HHE, 8-OHG, and 3-Cl-Tyr 
were significantly elevated in pre-shift and post-shift 
samples in the workers versus controls (p < 0.05). In 
addition, they correlated with MDA, HNE, 8-isoprostane, 
8-OHdG, 5-OHMeU, o-Tyr, and 3-Cl-Tyr of the same 
sample (p < 0.05). Again, pre-shift markers were already 
elevated.
20/19




Czech Republic Fe oxides (81–98 % of 
particles <100 nm)
All markers of oxidation of lipids, nucleic acids, and 
proteins (MDA, HNE, HHE, C6–C11, 8-isoprostane, 8-
OHdG, 8-OHG, 5-OHMeU, 3-Cl-Tyr, 3-NOTyr, o-Tyr), 
and LTB4 examined in post-shift EBC were elevated (p < 
0.001); C12 p value, < 0.05. There was no increase in 
cysteinyl LTs, pH, or FENO. No markers were increased 
in analyzed urine specimens
14/14
 Vermeulen et al. 
(2014) (2014 
EPICOH)
Netherlands CNTs Concentrations of cytokines were exposure-dependently 
upregulated, with higher levels among operators than 
R&D workers; levels for both were higher than unexposed 





 Liou et al. (2013) 
(2013 EPICOH)





No significant difference was revealed between exposed 
workers and controls in the changes of all markers, 
including lung injury markers, cardiovascular disease 
markers, heart rate variability (HRV), inflammation 
markers, oxidative stress and lipid peroxidation markers, 
206/140 
followed 
up no less 
than 2 
times
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Study type, authors, 
year (presentation)





comet assay, pulmonary function test, and neurobehavioral 
test, in this 4-year follow-up study
 Cui (2013) (PhD 
thesis)
China Calcium carbonate No significant cross-shift effect for FEV1, BP, and EENO 66–102/0




Czech Republic TiO2 (70–90 % of 
particles <100 nm)
In 2013, all markers of oxidation of lipids, nucleic acids, 
and proteins (MDA, HNE, HHE, C6–C11, 8-isoprostane, 8-
OHdG, 8-OHG, 5-OHMeU, 3-Cl-Tyr, 3-NOTyr, o-Tyr), 
and LTB4 in EBC were elevated (p < 0.001); C12 p value 
was < 0.05 in 2013 versus unexposed controls. The 
following post-shift markers in 2013 were elevated versus 
post-shift markers in 2012: C9, C12, 8-isoprostane, 8-
OHdG, 5-OHMeU, and 3-NOTyr. There was no difference 
in EENO, pH, and LTs, except for LTC4. No markers were 
increased in analyzed urine specimens in 2013, when 
exposure to TiO2 decreased
14/25
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Table 4
Emission of nanomaterials in different operations or processes in the nanotechnology industry in Taiwan
Operation Emission of nanomaterials
Coating of nanomaterials (enclosed) Quite low
Mixing/grinding of nanopigments (enclosed) Quite low
Synthesis of nanomaterials (wet process) Quite low
Centrifuge of nanomaterials (wet process) Quite low






Source Institute of Occupational Safety and Health (2012) Applications of the Newly Developed Nanoparticles Exposure Assessment Techniques 
to Workplaces in Nanoindustries (II). IOSH 101-H322
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